Blog | HemaCare

HemaCare's Peripheral Blood Helps Solve a Multiple Sclerosis Riddle

Feb 22, 2016 1:00:04 PM / by Maria posted in B Cells, Autoimmune Disorders, T Cells, Basic Research

0 Comments

Depleting B cells improves outcomes for multiple sclerosis patients, but what is the underlying biology? Peripheral blood from HemaCare helped provide answers.

 

Multiple sclerosis is a disease in which the protective myelin coat of nerve cells in the brain and spinal cord become damaged. Consequently, any function related to the central nervous system can be adversely affected, but the most common symptoms are severe fatigue, visual problems, altered sensitivity, and reduced mobility. The root cause of multiple sclerosis is still unknown, but the research community has learned that it is an abnormal immune-mediated response that attacks the myelin coating.

Read More

Using Dendritic Cells to Arm the Immune System via Dying Cancer Cells

Mar 16, 2015 1:00:25 PM / by Daisy Goodrich posted in B Cells, Cancer, Dendritic Cells, Basic Research

0 Comments

Scientists are exploring localized treatment in follicular lymphoma (FL) using dendritic cells that could have long-range benefits on all FL lesions.

Read More

Take 2: Several rounds of DNA rearrangements by B cells for perfecting that antibody

Nov 24, 2014 1:00:48 PM / by Daisy Goodrich posted in B Cells, Vaccine Research

0 Comments

B cells orchestrate mutations on cue. The procedure for antibody development requires a second take to get the performance right.

Read More

How Does Glatiramer Acetate Affect B Cells in Multiple Sclerosis?

Nov 17, 2014 1:00:36 PM / by Daisy Goodrich posted in B Cells, Autoimmune Disorders, PBMCs

0 Comments

Although glatiramer acetate has been around for about 20 years, we still do not have the full picture of its mode of action, especially on B cells.

Read More

Trichostatin A: A Better Way to Target Chronic Lymphocytic Leukemia Cells?

Oct 27, 2014 1:00:02 PM / by Shweta posted in B Cells, Bone Marrow, Cancer, Cell Therapy, Drug Discovery, PBMCs, Basic Research

0 Comments

Scientists have shown that trichostatin A could be a potent apoptosis inducer to target chronic lymphocytic leukemia cells.

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts